1. Home
  2. TENX vs HFBL Comparison

TENX vs HFBL Comparison

Compare TENX & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.72

Market Cap

74.1M

Sector

Health Care

ML Signal

N/A

Logo Home Federal Bancorp Inc. of Louisiana

HFBL

Home Federal Bancorp Inc. of Louisiana

N/A

Current Price

$20.06

Market Cap

73.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
HFBL
Founded
1967
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
73.1M
IPO Year
2001
2010

Fundamental Metrics

Financial Performance
Metric
TENX
HFBL
Price
$1.72
$20.06
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $9.63
N/A
AVG Volume (30 Days)
★ 2.0M
3.5K
Earning Date
11-11-2026
11-10-2026
Dividend Yield
N/A
★ 2.92%
EPS Growth
N/A
★ 60.32
EPS
N/A
★ 2.02
Revenue
N/A
★ $1,694,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.16
Revenue Growth
N/A
★ 30.01
52 Week Low
$1.31
$14.47
52 Week High
$19.40
$28.00

Technical Indicators

Market Signals
Indicator
TENX
HFBL
Relative Strength Index (RSI) 42.67 27.17
Support Level $1.34 $19.95
Resistance Level $2.00 $23.87
Average True Range (ATR) 0.12 0.75
MACD 0.09 -0.55
Stochastic Oscillator 70.91 3.55

Price Performance

Historical Comparison
TENX
HFBL

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. Through its subsidiary, a federally chartered stock savings bank, it provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial, and multi-family segments. The company also invests in securities held-to-maturity and securities available for sale.

Share on Social Networks: